Axovant to Present at First Annual Roivant Pipeline Day
June 18 2018 - 08:30AM
Axovant Sciences (NASDAQ:AXON) today announced that Pavan Cheruvu,
M.D., chief executive officer, will present a corporate overview at
the first annual Roivant Pipeline Day on July 10, 2018 at 4:30 p.m.
ET.
A live webcast will be available in the
Investors section of Axovant's website at www.axovant.com. A replay
will be available for 30 days following the conference.
About Roivant Pipeline Day
Roivant Pipeline Day will be held on Tuesday,
July 10, 2018 in New York City. The event will feature
presentations, fireside chats, and Q&A sessions from executives
across the Roivant family of companies. The event is scheduled to
begin at 2:00 p.m. ET and will continue until approximately 5:30
p.m. ET. Due to limited capacity, attendance is by invitation only
but a live webcast will be available to interested parties. To
request access to the webcast or to learn more about the event,
please email pipelineday@roivant.com.
About Axovant Sciences
Axovant is a clinical-stage biopharmaceutical
company focused on the acquisition, development and
commercialization of novel therapeutics in the fields of neurology
and psychiatry. We are developing a pipeline of clinical and
nonclinical product candidates that focuses on the various aspects
of debilitating neurodegenerative diseases such as Parkinson’s
disease, Alzheimer's disease, Lewy body dementia, and other
indications in the fields of neurology and psychiatry. Our goal is
to be the leading biopharmaceutical company focused on the fields
of neurology and psychiatry.
For more information, visit www.axovant.com.
Contacts:
Investors
Tricia Truehart(631) 892-7014investors@axovant.com
Media
Paul Davis(646) 495-5310media@axovant.com
SOURCE Axovant Sciences
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From Feb 2024 to Mar 2024
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From Mar 2023 to Mar 2024